HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Selsun Blue, Gold Bond Drive Chattem Sales 5% In 2003

This article was originally published in The Rose Sheet

Executive Summary

Chattem's efforts to expand distribution and strengthen its advertising strategy for Selsun Blue drove sales of the brand up 21%, helping to boost overall sales 5% to $233.7 mil. in fiscal 2003 (ended Nov. 30), the firm said in a Jan. 23 Q4 and full year earnings release

You may also be interested in...



Chattem Leaps Into 2005 With BullFrog, Phisoderm Extensions

Chattem is aiming to revitalize the pHisoderm brand with the launch of a new skin care line,pH20 by pHisoderm, early next year, the firm said

Chattem Leaps Into 2005 With BullFrog, Phisoderm Extensions

Chattem is aiming to revitalize the pHisoderm brand with the launch of a new skin care line,pH20 by pHisoderm, early next year, the firm said

Chattem Advertising Strategy Relies On “Guerrilla” Tactics – CEO Guerry

Chattem's advertising strategy focuses on acquiring media time "as a guerilla buyer as opposed to a big buyer," CEO Zan Guerry maintained at a Banc of America Securities consumer conference in New York April 8-10

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011847

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel